Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic fatty liver disease, Spanish investigators report in

Published
17 August 2017
By
Michael Carter
Peripheral artery disease more common in people with HIV with lower CD4 counts

Peripheral artery disease, one of the most common forms of cardiovascular disease, occurs more frequently in people with HIV who have CD4 cell counts below

Published
15 August 2017
By
Keith Alcorn
Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

The incidence of anal cancer among HIV-positive gay men peaked in 2009 and will decline substantially by 2030, even with current levels of antiretroviral therapy

Published
11 August 2017
By
Michael Carter
Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

Switching from a boosted protease inhibitor to the integrase inhibitor dolutegravir was associated with lipid reductions in people with HIV at higher risk of heart

Published
09 August 2017
By
Keith Alcorn
Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

Doctors need to monitor patients regularly for kidney function if they are taking tenofovir disoproxil, especially if combined with ritonavir, the 9th International AIDS Society Conference on HIV

Published
27 July 2017
By
Gus Cairns
HIV: MSF concerned by high numbers of AIDS deaths in sub-Saharan Africa

Global attention is needed to prevent and treat AIDS in antiretroviral era, with 50 per cent of hospital admissions in MSF hospitals already on treatment and showing signs of clinical failure.

Published
25 July 2017
From
Médecins Sans Frontières (MSF) International
Improved treatment for cryptococcal meningitis in HIV could save thousands of lives – if generic drug becomes available

Urgent action is needed to improve access to the antifungal drug flucytosine, say investigators, following the presentation of the results of a trial showing that treatment containing

Published
24 July 2017
By
Keith Alcorn
WHO recommends package of tests, treatment and prevention for 'urgent need' people with HIV with low CD4 counts

A new package of measures to ensure rapid initiation of antiretroviral treatment and diagnosis of opportunistic infections has been recommended by the World Health Organization (WHO) to

Published
23 July 2017
By
Keith Alcorn
Boys Are Being Denied A Vaccine That Prevents Cancer. Why Is This Being Allowed To Happen?

Yesterday, a short-sighted and shameful recommendation was made not to give teenage boys the potentially life-saving Human Papilloma Virus (HPV) vaccine.

Published
21 July 2017
From
Huffington Post
Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

Only a few people starting an integrase inhibitor discontinue the treatment during the first year of therapy due to drug-related toxicities, investigators from Switzerland report in an advance

Published
21 July 2017
By
Michael Carter
← First12345...157Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.